Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4 instead of the previous v3.5.3. This indicates an updated release/version identifier for the page rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-05-15T09:30:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s footer software/version marker was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than content changes to the clinical study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:12:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:50.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision update added: v3.5.0. Revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:30:47.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T23:36:11.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1; changes are limited to site version metadata and the removal of a non-critical government-funding maintenance notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T12:18:26.000Z thumbnail image

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.